特朗普政府宣布将结束由拜登政府于2024年实施的一项Medicare处方药补贴计划[1]。该补贴项目旨在降低老年人Medicare Part D处方药成本，约2500万美国人持有该计划[1]。
补贴将于2027年结束，这意味着大量老年人将面临月度保险费用上升[1]。2026年，该补贴项目花费约36亿美元，平均每位受益人每月抵消16美元的保险费[1]。目前，Part D受益人在有补贴情况下的平均月度保费为36美元[1]。医疗保险和医疗补助中心（CMS）管理员梅赫迈特·奥兹表示，大多数受益人的月度保费增幅将少于10美元[1]。新的保费信息预计在9月发布[1]。
The Trump administration has announced the termination of a temporary prescription drug subsidy initiative for Medicare beneficiaries, a program that was implemented by the Biden administration in 2024 to reduce out-of-pocket costs for seniors enrolled in Medicare Part D plans.[1] The decision to end the subsidy has sparked political controversy in an election year, despite claims from government officials that the impact will be minimal.
Approximately 25 million Americans currently hold Medicare Part D coverage.[1] The subsidy program cost roughly $3.6 billion in 2026 and reduced monthly insurance premiums by an average of $16 for eligible beneficiaries that year.[1] Current Part D enrollees pay an average monthly premium of $36 with the subsidy in place.[1] The termination is set to take effect in 2027,[1] and updated premium information will be released in September.[1] CMS Administrator Mehmet Oz stated that most beneficiaries would experience monthly premium increases of less than $10.[1]